Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
Saved in:
Main Authors: | Masahiro Kikuchi, Miho Kikuchi, Masahiro Konishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-09-01
|
Series: | Clinical & Experimental Hepatology |
Subjects: | |
Online Access: | https://www.termedia.pl/Usefulness-of-pemafibrate-for-non-alcoholic-fatty-liver-disease-with-hypertriglyceridemia,80,54786,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01) -
Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01) -
An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01) -
Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005–2016
by: Yidian Fu, et al.
Published: (2025-01-01) -
Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)